SEC Form 4 · accession 0001562180-18-002457
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J. Christmas
Officer — SVP, General Counsel
Period of report
May 9, 2018
Accepted (ET)
May 11, 2018 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2018 | M | 15,000 | $12.10 | A | 16,141 | D | |
| Common Stock | May 9, 2018 | S | 5,000 | $42.00 | D | 11,141 | D | |
| Common Stock | May 9, 2018 | S | 10,000 | $44.00 | D | 1,141 | D | |
| Common Stock | May 10, 2018 | M | 15,000 | $12.10 | A | 16,141 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $12.10 | May 9, 2018 | M | 15,000 | D | — | Aug 17, 2026 | Common Stock | 15,000 | 90,000 | D |
| Employee Stock Option (Right to Buy)F2 | $12.10 | May 10, 2018 | M | 15,000 | D | — | Aug 17, 2026 | Common Stock | 15,000 | 75,000 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F2The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer.